Skip to main content
Figure 2 | BMC Nephrology

Figure 2

From: A multicenter, randomized, double-blind study comparing different FK778 doses (manitimus) with tacrolimus and steroids vs. MMF with tacrolimus and steroids in renal transplantation

Figure 2

Mean Total Daily Dose (mg/kg) of Tacrolimus taken by Patients included in the Intent to Treat Population. The mean tacrolimus dose differed across the treatment groups throughout the study being generally highest in the high level FK778 group and lowest in the MMF group. In all treatment groups tacrolimus doses were highest during the first 3 to 4 weeks of the study and then gradually declined throughout the study.

Back to article page